Stock Track | Camp4 Therapeutics Soars 2690% in Trading Debut After $75 Million IPO

Stock Track

2024-10-12

Shares of Camp4 Therapeutics Corp. (CAMP) skyrocketed 2690% in their trading debut on Friday, following the biotechnology company's successful $75 million initial public offering (IPO).

Camp4 Therapeutics priced its IPO of around 6.8 million common shares at $11 per share on Thursday evening. The company granted underwriters a 30-day option to purchase up to an additional 1 million shares.

The robust trading debut reflects strong investor demand for the newly public biotech firm, which is focused on developing novel therapies for cancer and other diseases. Camp4's IPO proceeds will help fund ongoing research and development activities as the company advances its pipeline of innovative drug candidates.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1153411982"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1153411982\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/1153411982?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-12 00:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1153411982","market":"hk","top_or_hot":-1,"title":"Stock Track | Camp4 Therapeutics Soars 2690% in Trading Debut After $75 Million IPO","media":"Stock Track","content":"<p>Shares of Camp4 Therapeutics Corp. (CAMP) skyrocketed 2690% in their trading debut on Friday, following the biotechnology company's successful $75 million initial public offering (IPO).</p>\n\n<p>Camp4 Therapeutics priced its IPO of around 6.8 million common shares at $11 per share on Thursday evening. The company granted underwriters a 30-day option to purchase up to an additional 1 million shares.</p>\n\n<p>The robust trading debut reflects strong investor demand for the newly public biotech firm, which is focused on developing novel therapies for cancer and other diseases. Camp4's IPO proceeds will help fund ongoing research and development activities as the company advances its pipeline of innovative drug candidates.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Camp4 Therapeutics Soars 2690% in Trading Debut After $75 Million IPO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Camp4 Therapeutics Soars 2690% in Trading Debut After $75 Million IPO\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2024-10-12 00:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of Camp4 Therapeutics Corp. (CAMP) skyrocketed 2690% in their trading debut on Friday, following the biotechnology company's successful $75 million initial public offering (IPO).</p>\n\n<p>Camp4 Therapeutics priced its IPO of around 6.8 million common shares at $11 per share on Thursday evening. The company granted underwriters a 30-day option to purchase up to an additional 1 million shares.</p>\n\n<p>The robust trading debut reflects strong investor demand for the newly public biotech firm, which is focused on developing novel therapies for cancer and other diseases. Camp4's IPO proceeds will help fund ongoing research and development activities as the company advances its pipeline of innovative drug candidates.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CAMP","symbol_name":"Camp4 Therapeutics Corp.","start_time":0,"source_url":"","article_id":"1153411982","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1153411982","pubTimestamp":1728663020,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Camp4 Therapeutics Corp.  skyrocketed 2690% in their trading debut on Friday, following the biotechnology company's successful $75 million initial public offering .Camp4 Therapeutics priced its IPO of around 6.8 million common shares at $11 per share on Thursday evening. The company granted underwriters a 30-day option to purchase up to an additional 1 million shares.The robust trading debut reflects strong investor demand for the newly public biotech firm, which is focused on developi","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CAMP":"Camp4 Therapeutics Corp."},"translate_title":"股票轨迹Camp4 Therapeutics IPO 7500万美元后首次交易飙升2690%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CAMP":1},"content_text":"Shares of Camp4 Therapeutics Corp. (CAMP) skyrocketed 2690% in their trading debut on Friday, following the biotechnology company's successful $75 million initial public offering (IPO).\nCamp4 Therapeutics priced its IPO of around 6.8 million common shares at $11 per share on Thursday evening. The company granted underwriters a 30-day option to purchase up to an additional 1 million shares.\nThe robust trading debut reflects strong investor demand for the newly public biotech firm, which is focused on developing novel therapies for cancer and other diseases. Camp4's IPO proceeds will help fund ongoing research and development activities as the company advances its pipeline of innovative drug candidates.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"}}}